Russell Frank Company’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Russell Frank Company’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$12.1M	Buy	226,757 +153,080	+208%	+$11.3M	0.02%	830
2015 Q4	$8.27M	Buy	73,677 +16,632	+29%	+$1.83M	0.01%	991
2015 Q3	$6.71M	Sell	57,045 -64,731	-53%	-$8.45M	0.01%	1103
2015 Q2	$9.43M	Buy	121,776 +57,872	+91%	+$3.79M	0.02%	1028
2015 Q1	$3.7M	Buy	63,904 +31,849	+99%	+$1.35M	0.01%	1424
2014 Q4	$1.03M	Sell	32,055 -8,383	-21%	-$252K	﹤0.01%	2121
2014 Q3	$990K	Hold	40,438	–	–	﹤0.01%	2067
2014 Q2	$674K	Sell	40,438 -54,589	-57%	-$879K	﹤0.01%	2229
2014 Q1	$1.55M	Sell	95,027 -13,625	-13%	-$264K	﹤0.01%	1884
2013 Q4	$2.09M	Sell	108,652 -45,232	-29%	-$626K	﹤0.01%	1697
2013 Q3	$1.63M	Buy	153,884 +153,779	+146,456%	+$1.35M	﹤0.01%	1965
2013 Q2	$1K	Buy	+105	New	+$636	﹤0.01%	3347

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Russell Frank Company's ANAC Position: Q1 2016 in Review

Russell Frank Company increased its ANACOR PHARMACEUTICALS INC COM (ANAC) stake by 208% in Q1 2016, buying an estimated $11.3M and bringing the position to 226,757 shares worth $12.1M. The position accounts for 0.02% of the portfolio, ranked #830.

Russell Frank Company first reported a position in ANAC in Q2 2013 and has held it in 12 quarters since. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

Russell Frank Company held 226,757 shares of ANACOR PHARMACEUTICALS INC COM worth $12.1M as of Q1 2016.
Russell Frank Company bought 153,080 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $11.3M.
ANACOR PHARMACEUTICALS INC COM made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #830 holding.
Russell Frank Company first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and has held it in 12 quarters since.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.